BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2015

Jan 28, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2015-01-26

Reporting Person: Powell Lynne (Senior VP - CCO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-01-26	Common Stock	A	10000	—	Acquired	10000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-01-26	Emp. Stock Option (Right to Buy)	$11.33	A	190000	Acquired	2025-01-26	Common Stock (190000)	Direct

Footnotes

F1: Initial award of Restricted Stock Units which will vest 100% on the first anniversary of the date of grant.

F2: Initial Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.